ReposiTrak Delivers Full-Year Revenue of $20.5 Million and Earnings Per Share of $0.30

Rhea-AI Summary

ReposiTrak (NYSE: TRAK) reported financial results for FY2024 and Q4 2024. Full-year revenue increased 7% to $20.5 million, with recurring revenue up 7% to $20.4 million. Full-year GAAP net income rose 7% to $5.9 million, with EPS of $0.30, up 11% year-over-year. Q4 revenue grew 8% to $5.2 million, with GAAP net income up 15% to $1.6 million.

The company ended the year with $25.2 million in cash and no bank debt. ReposiTrak's Board approved a 10% increase in the quarterly common stock dividend. The company redeemed 81,121 preferred shares for $867,995 during Q4. CEO Randall K. Fields highlighted the accelerating on-boarding pace of the ReposiTrak Traceability Network and expects revenue growth to follow in coming quarters.

Positive

• Full-year revenue increased 7% to $20.5 million
• Full-year GAAP net income rose 7% to $5.9 million
• EPS increased 11% to $0.30 for the full year
• Q4 revenue grew 8% to $5.2 million
• Q4 GAAP net income up 15% to $1.6 million
• Cash position strengthened to $25.2 million with no bank debt
• 10% increase in quarterly common stock dividend approved
• Accelerating on-boarding pace of ReposiTrak Traceability Network

Negative

• Full-year operating expense increased 10% to $15.4 million
• Full-year operating income remained flat at $5.0 million

Insights

Financial Analyst

ReposiTrak's fiscal 2024 results show solid performance with 7% revenue growth to $20.5 million and 11% EPS growth to $0.30. The company's focus on traceability is paying off, with accelerating on-boarding pace expected to drive future revenue growth. Key positives include:

• Recurring revenue up 7% to $20.4 million
• Operating income of $5.0 million, flat year-over-year but up $1.3 million excluding prior year's ERC credit
• Strong cash position of $25.2 million with no debt
• 10% increase in quarterly dividend

The company's ability to grow all business lines while focusing on traceability demonstrates strong execution. With $7.0 million in operating cash flow and a healthy balance sheet, ReposiTrak is well-positioned for continued growth and shareholder returns.

Market Research Analyst

ReposiTrak's position as the traceability market leader is a significant competitive advantage in the food safety and compliance sector. The accelerating on-boarding pace for the ReposiTrak Traceability Network (RTN) suggests strong market demand and potential for sustained growth. Key market implications include:

• Increasing industry focus on food traceability, driven by regulatory requirements and consumer demand
• ReposiTrak's platform gaining traction, indicating potential market share gains
• Recurring revenue model (99.5% of total revenue) provides stability and predictability

The company's ability to grow all business lines while prioritizing traceability demonstrates the strength of its diversified offerings. With a strong cash position and no debt, ReposiTrak is well-equipped to invest in further innovation and potential strategic acquisitions to solidify its market leadership.

Traceability On-Boarding Continues to Accelerate

Company Increases Quarterly Common Dividend

SALT LAKE CITY--(BUSINESS WIRE)-- ReposiTrak (NYSE: TRAK), the world's largest food traceability and regulatory compliance network, built upon its proven inventory management and out-of-stock reduction SaaS platform, today announced financial results for the fourth fiscal quarter (“FQ4 2024”) and full fiscal year ended June 30, 2024.

Full-Year Fiscal 2024 Financial Highlights:

• Full-year total revenue increased 7% to $20.5 million from $19.1 million.
• Recurring revenue increased 7%, net of the planned elimination of high-touch, low-opportunity revenue, to $20.4 million from $19.0 million.
• Full-year operating expense increased 10% to $15.4 million from $14.0 million. Fiscal 2023 included approximately $1.4 million in an Employee Retention Credit (“ERC”), reducing general and administrative expense in fiscal 2023, which did not reoccur in fiscal 2024.
• Full-year operating income was $5.0 million in fiscal 2024 from $5.1 million last year – essentially flat. Excluding the non-recurring ERC credit in fiscal 2023, operating income would have increased approximately $1.3 million year-over-year.
• Full-year GAAP net income increased 7% to $5.9 million from $5.6 million last year. Excluding the non-recurring ERC credit in the third fiscal quarter last year, net income would have increased approximately $1.4 million year-over-year.
• Full-year net income to common shareholders was $5.4 million, up 8% from $5.0 million last year. Excluding the non-recurring ERC credit in the prior fiscal year, net income to common shareholders would have increased approximately $1.4 million year-over-year.
• Full-year basic EPS of $0.30, up 11% compared to $0.27 last year.
• The Company finished the year with $25.2 million in cash and no bank debt.
• ReposiTrak’s Board of Directors approved a 10% increase to the Company’s quarterly common stock dividend, beginning with the dividend payable to shareholders of record on December 31, 2024.

Fourth Quarter Financial Highlights:

• Fourth quarter total revenue increased 8% to $5.2 million from $4.8 million.
• Recurring revenue increased 7%, net of the planned elimination of high-touch, low-opportunity revenue, to $5.1 million from $4.8 million, representing effectively all of total revenue.
• Quarterly operating expense increased 6% to $3.9 million from $3.6 million.
• Quarterly operating income increased 13% to $1.3 million from $1.2 million last year.
• Quarterly GAAP net income increased 15% to $1.6 million from $1.4 million last year.
• Quarterly net income to common shareholders was $1.5 million, up 18% from $1.2 million last year.
• Quarterly EPS of $0.08 compared to $0.07 in the prior year fourth fiscal quarter.
• During the quarter, the Company redeemed 81,121 preferred shares for the stated redemption price of $10.70 per share for a total of $867,995.

Randall K. Fields, Chairman and CEO of ReposiTrak, commented, “Our strategic position and operational results of the ReposiTrak Traceability Network (RTN) continues to exceed our expectations. We are the traceability market leader. Our on-boarding pace is accelerating and, as a result, our revenue growth will follow suit over the next few quarters.”

Fields continued, “In fiscal 2024, we grew every line of business, including compliance and scan-based trading, even as we focused our resources on traceability. We delivered full-year earnings per share of $0.30, generated net cash from operations of $7.0 million, and ended the fiscal year with more than $25 million cash in the bank, the highest level in our history. This profitability allowed us to return over $5.6 million in capital to shareholders this fiscal year through a growing cash dividend, the repurchase of common stock and the redemption of preferred stock.”

Fourth Fiscal Quarter Financial Results (three months ended June 30, 2024, vs. three months ended June 30, 2023):

Total revenue was up 8% to $5.2 million as compared to $4.8 million in the prior-year fourth quarter. Total operating expense was $3.9 million, up 6% compared to $3.6 million last year. General and administrative expense increased by 4%. GAAP net income was $1.6 million compared to $1.4 million. Net income to common shareholders was $1.5 million, or $0.08 per diluted share, compared to $1.2 million, or $0.07 per diluted share.

Year-to-Date Financial Results (12 months ended June 30, 2024, vs. 12 months ended June 30, 2023):

Total revenue was up 7% to $20.5 million as compared to $19.1 million in the prior-year period. Total operating expense was $15.4 million, up 10% compared to $14.0 million last year. Last fiscal year included a non-recurring Employee Retention Credit benefit of approximately $1.4 million, reducing the year-ago operating expense. Inclusive of the impact of this credit in the year-ago quarter, GAAP net income was $6.0 million compared to $5.6 million. Net income to common shareholders was $5.4 million, or $0.30 per basic and $0.29 per diluted share, compared to $5.0 million, or $0.27 per basic and diluted share last year.

Return of Capital:

In the fourth quarter of fiscal 2024, the Company redeemed 81,121 preferred shares at the stated redemption price of $10.70 per share for a total of $867,995. To date, the Company has redeemed 221,307 shares of preferred stock for a total of $2.4 million. The remaining amount of the preferred share redemption is $6.6 million. As previously announced, the Company anticipates redeeming all of its preferred shares issued and outstanding over the next three years. In addition, the Company has approximately $8 million remaining of the $21 million total common share buyback authorization.

In September 2022, the Company’s Board of Directors declared a quarterly cash dividend of $0.015 per share ($0.06 per year). In November 2023, the Board of Directors approved a 10% increase in the quarterly cash dividend, to 6.6 cents per share annually, or 1.65 cents per share quarterly, commencing with the December 2023 dividend. On June 18, 2024, the Company's Board of Directors declared a quarterly cash dividend of $0.0165 per share, payable to shareholders of record on June 28, 2024. The cash dividends were paid to shareholders of record on or about August 12, 2024.

Balance Sheet:

The Company had $25.2 million in cash and cash equivalents at June 30, 2024, compared to $24.0 million at June 30, 2023. In March 2024, the Company chose not to renew its working line of credit. As of June 30, 2024, there were no balances due on the line of credit.

Conference Call:

The Company will host a conference call at 4:15 p.m. Eastern today to discuss the Company’s results. The conference call will also be webcast and will be available via the investor relations section of the Company’s website, www.parkcitygroup.com.

Participant Dial-In Numbers:
Date: Monday, September 30, 2024
Time: 4:15 p.m. ET (1:15 p.m. PT)
Toll-Free: 1-877-407-9716
Toll/International 1-201-493-6779
Conference ID: 13748737

Replay Dial-In Numbers:
Toll Free: 1-844-512-2921
Toll/International: 1-412-317-6671
Replay Start: Monday, September 30, 2024, 7:15 p.m. ET
Replay Expiry: Wednesday, October 30, 2024, at 11:59 p.m. ET
Replay Pin Number: 13748737

About ReposiTrak

ReposiTrak (NYSE:TRAK), formerly Park City Group, provides retailers, suppliers and wholesalers with a robust solution suite to help reduce risk and remain in compliance with regulatory requirements, enhance operational controls and increase sales with unrivaled brand protection. Consisting of three product families – food traceability, compliance and risk management and supply chain solutions – ReposiTrak’s integrated, cloud-based applications are supported by an unparalleled team of experts. For more information, visit https://repositrak.com.

Forward-Looking Statement

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “if,” “should” and “will” and similar expressions as they relate to ReposiTrak Inc., Park City Group d/b/a ReposiTrak, or Park City Group, Inc. (“ReposiTrak”) are intended to identify such forward-looking statements. ReposiTrak may from time-to-time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see “Risk Factors” in ReposiTrak annual report on Form 10-K, its quarterly report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

REPOSITRAK, INC. Consolidated Balance Sheets
		June 30,				June 30,
		2024				2023
Assets
Current Assets
Cash		$	25,153,862			$	23,990,879
Receivables, net of allowance for doubtful accounts of $227,573 and $170,103 at June 30, 2024 and 2023, respectively			3,678,627				2,523,019
Contract asset – unbilled current portion			181,680				186,959
Prepaid expense and other current assets			285,998				573,763
Total Current Assets			29,300,167				27,274,620
Property and equipment, net			513,277				986,300
Other Assets:
Deposits and other assets			22,414				22,414
Prepaid expense – less current portion			2,609				36,282
Contract asset – unbilled long-term portion			108,052				108,052
Operating lease – right-of-use asset			250,306				310,796
Customer relationships			131,400				262,800
Goodwill			20,883,886				20,883,886
Capitalized software costs, net			384,621				698,281
Total Other Assets			21,783,288				22,322,511
Total Assets		$	51,596,732			$	50,583,431
Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable		$	265,086			$	431,387
Accrued liabilities			1,554,775				1,620,000
Contract liability – deferred revenue			2,441,234				1,903,001
Operating lease liability – current			64,076				58,771
Notes payable and financing leases – current			217,971				219,262
Total current liabilities			4,543,142				4,232,421
Long-term liabilities
Operating lease liability – less current portion			198,972				263,047
Notes payable and financing leases – less current portion			-				206,032
Total liabilities			4,742,114				4,701,500
Commitments and contingencies
Stockholders’ equity:
Preferred Stock; $0.01 par value, 30,000,000 shares authorized;
Series B Preferred, 700,000 shares authorized; 616,470 and 625,375 shares issued and outstanding at June 30, 2024 and 2023, respectively			6,165				6,254
Series B-1 Preferred, 550,000 shares authorized; 0 and 212,402 shares issued and outstanding at June 30, 2024 and 2023, respectively			-				2,124
Common Stock, $0.01 par value, 50,000,000 shares authorized; 18,234,893 and 18,309,051 issued and outstanding at June 30, 2024 and 2023, respectively			182,351				183,093
Additional paid-in capital			64,655,902				67,732,887
Accumulated other comprehensive loss			(27,390	)			-
Accumulated deficit			(17,962,410	)			(22,042,427	)
Total stockholders’ equity			46,854,618				45,881,931
Total liabilities and stockholders’ equity		$	51,596,732			$	50,583,431

REPOSITRAK, INC. Consolidated Statements of Operations
		For the Years Ended
		June 30,
		2024				2023
Revenue		$	20,453,320			$	19,098,910
Operating expense:
Cost of revenue and product support			3,416,450				3,309,345
Sales and marketing			5,492,719				4,933,405
General and administrative			5,330,437				4,685,783
Depreciation and amortization			1,189,483				1,079,799
Total operating expense			15,429,089				14,008,332
Income from operations			5,024,231				5,090,578
Other income (expense):
Interest income			1,272,719				821,777
Interest expense			(28,166	)			(60,990	)
Unrealized gain (loss) on short term investments			63,997				(9,752	)
Other gain			-				70,047
Income before income taxes			6,332,781				5,911,660
(Provision) for income taxes			(374,491	)			(321,371	)
Net income			5,958,290				5,590,289
Dividends on Preferred Stock			(549,645	)			(586,444	)
Net income applicable to common shareholders		$	5,408,645			$	5,003,845
Weighted average shares, basic			18,202,000				18,406,000
Weighted average shares, diluted			18,931,000				18,766,000
Basic earnings per share		$	0.30			$	0.27
Diluted earnings per share		$	0.29			$	0.27
Comprehensive income:
Net income		$	5,958,290			$	5,590,289
Other comprehensive loss:
Unrealized loss on available-for-sale securities			(27,390	)			-
Total comprehensive income		$	5,930,900			$	5,590,289

REPOSITRAK, INC. AND SUBSIDIARIES Consolidated Statements of Cash Flows
		For the Years Ended
		June 30,
		2024				2023
Cash flows from operating activities:
Net income		$	5,958,290			$	5,590,289
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			1,189,483				1,079,799
Amortization of operating right of use asset			60,490				57,716
Stock compensation expense			367,147				390,716
Bad debt expense			375,000				1,300,000
(Increase) decrease in:
Accounts receivables			(1,525,329	)			(195,345	)
Long-term receivables, prepaids and other assets			123,355				559,009
Increase (decrease) in:
Accounts payable			(166,301	)			(259,251	)
Operating lease liability			(58,770	)			(53,862	)
Accrued liabilities			102,803				43,090
Deferred revenue			538,233				347,858
Net cash provided by operating activities			6,964,401				8,860,019
Cash flows from investing activities:
Purchase of property and equipment			(73,317	)			(133,944	)
Capitalization of software development costs			-				(769,243	)
Purchase of marketable securities			(27,390	)			-
Net cash (used in) provided by investing activities			(100,707	)			(903,187	)
Cash flows from financing activities:
Net (decrease) in lines of credit			-				(2,590,907	)
Common stock buyback/retirement			(1,515,574	)			(1,309,323	)
Redemption of Series B-1 preferred			(2,367,996	)			-
Proceeds from employee stock plan			111,839				92,727
Dividends paid			(1,721,657	)			(1,414,912	)
Payments on notes payable and capital leases			(207,323	)			(204,486	)
Net cash used in financing activities			(5,700,711	)			(5,426,901	)
Net (decrease) increase in cash and cash equivalents			1,162,983				2,529,931
Cash and cash equivalents at beginning of period			23,990,879				21,460,948
Cash and cash equivalents at end of period		$	25,153,862			$	23,990,879
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes		$	332,222			$	296,484
Cash paid for interest		$	15,223			$	59,081
Cash paid for operating leases		$	73,291			$	71,157
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Common Stock to pay accrued liabilities		$	536,879			$	294,607
Dividends accrued on Preferred Stock		$	549,645			$	586,444

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240930993961/en/

Investor Relations Contact:

John Merrill, CFO

Investor-relations@repositrak.com

Or

FNK IR

Rob Fink

646.809.4048

rob@fnkir.com

Source: ReposiTrak

FAQ

What was ReposiTrak's (TRAK) revenue for fiscal year 2024?

ReposiTrak's total revenue for fiscal year 2024 increased 7% to $20.5 million from $19.1 million in the previous year.

How much did ReposiTrak's (TRAK) EPS grow in fiscal year 2024?

ReposiTrak reported full-year basic EPS of $0.30 for fiscal year 2024, up 11% compared to $0.27 in the previous year.

What was ReposiTrak's (TRAK) cash position at the end of fiscal year 2024?

ReposiTrak finished fiscal year 2024 with $25.2 million in cash and no bank debt.

Did ReposiTrak (TRAK) increase its dividend in fiscal year 2024?

Yes, ReposiTrak's Board of Directors approved a 10% increase to the Company's quarterly common stock dividend, beginning with the dividend payable to shareholders of record on December 31, 2024.